Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immucell Corp. (ICCC)
NASDAQ:ICCC
Immucell (ICCC) Stock Price & Analysis
67 Followers
ICCC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.26 - $6.05
Previous Close$5.17
Volume3.06K
Average Volume (3M)7.93K
Market Cap
$40.07M
Enterprise Value$54.77M
Total Cash (Recent Filing)$1.99M
Total Debt (Recent Filing)$16.68M
Price to Earnings (P/E)-6.9
Beta0.35
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.74
Shares Outstanding7,750,864
10 Day Avg. Volume7,734
30 Day Avg. Volume7,930
Standard Deviation0.13
R-Squared0.06
Alpha-0.00230
Financial Highlights & Ratios
Price to Book (P/B)1.55
Price to Sales (P/S)10.25
Price to Cash Flow (P/CF)-19.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.36
Enterprise Value/Gross Profit7.16
Enterprise Value/Ebitda-9.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Immucell News
Ownership Overview
20.10% Insiders
4.27% Mutual Funds
6.59% Other Institutional Investors
69.04% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ICCC FAQ
What was Immucell Corp.’s price range in the past 12 months?
Immucell Corp. lowest stock price was $4.26 and its highest was $6.05 in the past 12 months.
What is Immucell Corp.’s market cap?
Currently, no data Available
When is Immucell Corp.’s upcoming earnings report date?
Immucell Corp.’s upcoming earnings report date is May 09, 2024 which is in 20 days.
How were Immucell Corp.’s earnings last quarter?
Immucell Corp. released its earnings results on Feb 27, 2024. The company reported -$0.147 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.147.
Is Immucell Corp. overvalued?
According to Wall Street analysts Immucell Corp.’s price is currently Overvalued.
Does Immucell Corp. pay dividends?
Immucell Corp. does not currently pay dividends.
What is Immucell Corp.’s EPS estimate?
Immucell Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immucell Corp. have?
Immucell Corp. has 7,750,864 shares outstanding.
What happened to Immucell Corp.’s price movement after its last earnings report?
Immucell Corp. reported an EPS of -$0.147 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.556%.
Which hedge fund is a major shareholder of Immucell Corp.?
Currently, no hedge funds are holding shares in ICCC
---
Immucell Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.44%
12-Months-Change
Fundamentals
Return on Equity
-20.86%
Trailing 12-Months
Asset Growth
-2.35%
Trailing 12-Months
Company Description
Immucell Corp.
ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
---
ICCC Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
Intra-Cellular Therapies
―
Immutep
―
Pieris Pharmaceuticals
―
Adverum Biotechnologies
―
---